Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

50.38 +0.39 (+0.78%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Smart Money Is Betting Big In HIMS Options
Via Benzinga
1 Growth Stock on Our Buy List and 2 We Brush Off
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder
Via The Motley Fool
Topics Intellectual Property
WallStreetBets Trader Nuked Mom's $800K IRA, Then Flipped It Into $4 Million With Options In Just 3 Months: His Strategy? 'TACO's Gonna TACO'
A Reddit user claims to have turned disaster into triumph after nearly blowing his mother's $800,000 retirement account. 
Via Benzinga
Topics Retirement
Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list. 
Via Benzinga
Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent Expires
The telehealth company stated that its entry to Canada will come as generic semaglutide hits the market for the first time. 
Via Stocktwits
Topics Intellectual Property
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced plans to expand into Canada with a weight-loss solution centered on generic... 
Via StockStory
Topics Artificial Intelligence
What's Going On With Hims & Hers Health Stock Today?
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world. 
Via Benzinga
Oklo, NuScale, Hims Defy Trump Tariffs - And Power The Russell 2000 Toward New Highs
Small caps outshine tariff fears as Russell 2000 nears all-time highs. Oklo, NuScale, Hims lead with gains of over 95% YTD despite trade turmoil. 
Via Benzinga
Topics Government World Trade
Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits
Hims & Hers faces stock pressure after Novo Nordisk ends Wegovy access, citing compounding violations and marketing concerns. 
Via Benzinga
Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert
Popular obesity treatments Wegovy and Zepbound are seeing price reductions, but patients still face significant barriers to sustained access. 
Via Benzinga
3 Cash-Heavy Stocks Worth Investigating
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. 
Via StockStory
Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback
Hims & Hers stock dipped after Novo Nordisk pulled back its partnership for a weight loss drug distribution, though that may not mean much. 
Via MarketBeat
EXCLUSIVE: 2025's First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank?
A look at the top 20 most-searched tickers on Benzinga Pro for the first six months of 2025. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Best Stocks to Buy: Hims & Hers Stock vs. UnitedHealth Stock
Via The Motley Fool
Is Hims & Hers Stock in Trouble?
Via The Motley Fool
Topics Supply Chain
Where Will Hims & Hers Stock Be in 2030?
Via The Motley Fool
EXCLUSIVE: June's 20 Most-Searched Tickers On Benzinga Pro — Where Do CoreWeave, Nvidia, Apple Stock Rank?
A look at the top 20 most-searched stock tickers for the month of June on Benzinga Pro. 
Via Benzinga
Amazon Wants More Power
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes. 
Via The Motley Fool
Topics Artificial Intelligence
Great News for Hims & Hers Stock Investors
Via The Motley Fool
Circle Internet, Hims & Hers Health And CoreWeave Are Among Top 10 Large Cap Losers Last Week (June 23-27): Are The Others In Your Portfolio?
Last week's worst performers include CRCL, HIMS, VG, QXO, CRWV, DUOL, EQIX, EQNR, CF, and EC. Are they in your portfolio? 
Via Benzinga
Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Hims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth Stock
Via The Motley Fool
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash
Via The Motley Fool
Stocks making big moves this week: Torrid, Provident Financial Services, Bumble, Coinbase, and Hims & Hers Health
Check out the companies making headlines this week: 
Via StockStory
Topics Workforce
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies. 
Via The Motley Fool
Topics Intellectual Property
Massive News for Hims & Hers Stock Investors!
Via The Motley Fool
Down Over 30%, What's Going on With Hims & Hers stock?
Via The Motley Fool
2 Volatile Stocks Worth Your Attention and 1 to Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.